
Articles
-
1 week ago |
healio.com | P. Dee Stephenson |Alex Young |Nancy Hemphill
KIAWAH ISLAND, S.C. — In this exclusive Healio Video Perspective from Kiawah Eye, P. Dee Stephenson, MD, FACS, discusses toric IOL rotation and tips for achieving the correct alignment. Stephenson offered recommendations on the tools she uses and said the most important factor is to have stable refraction. That way, a surgeon can find where the alignment is off. “Toric implants help us so much, but if you’re off alignment, you can really negate what you’re there for,” she said.
-
1 week ago |
healio.com | Jennifer Loh |Alex Young |Nancy Hemphill
KIAWAH ISLAND, S.C. — In this exclusive Healio Video Perspective from Kiawah Eye, Jennifer M. Loh, MD, discusses her technique for IOL exchange. While there are several ways to remove an IOL, Loh’s preferred method has four steps: separating the anterior capsule from the IOL, freeing the IOL from the capsular bag and ensuring the haptics are movable, inserting the new IOL in the bag under the original IOL, and cutting and removing the old IOL.
-
1 week ago |
healio.com | Alex Young
Key takeaways: The pandemic was associated with an increased risk and magnitude of astigmatism. The prevalence of refractive and corneal astigmatism rose from 2015 to 2023. The prevalence and severity of refractive and corneal astigmatism in children rose after the COVID-19 pandemic, according to a study published in JAMA Ophthalmology.
-
2 weeks ago |
healio.com | Alex Young
Key takeaways: The approval allows for immediate treatment following diagnosis. Patients treated in a phase 3 study experienced sustained viral response. Editor’s note: This is a developing news story. Please check back soon for updates. FDA approved a label expansion for Mavyret for the treatment of acute hepatitis C virus, according to a press release from the manufacturer, AbbVie.
-
2 weeks ago |
healio.com | Srini Vas Sadda |Alex Young |Anthony DeFino
SALT LAKE CITY — In this Healio Video Perspective from the ARVO meeting, SriniVas R. Sadda, MD, FARVO, discusses a long-term study evaluating MCO-010 for the treatment of retinitis pigmentosa. Sadda said patients with retinitis pigmentosa experienced sustained improvements in visual acuity through 126 weeks after treatment with MCO-010 (Nanoscope Therapeutics). Additionally, the safety profile of the gene therapy was favorable, he said.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 160
- Tweets
- 96
- DMs Open
- No

RT @NJSP: Sadly, today marks the 1-year anniversary of the line-of-duty death of Trooper Sean Cullen. #GoneButNeverForgotten #Hero #ThinBlu…

RT @NJSP: Atlantic City boardwalk for Tpr. Frankie Williams. #GoneButNotForgotten #RIP https://t.co/Q9LCXj3UGM

RT @NJSP: Nothing says America like, well, America. For Summer '16 only, we're renaming ourselves. https://t.co/ex1NUa8l2J